In response to the current opioid epidemic, the FDA has been encouraging drug companies to create abuse-deterrent pain medications. These medications have properties that make it harder, or less rewarding, for a person to inject or snort them, and are typically resistant to crush or extraction. Some abuse-deterrent pain medications that you may have heard of include Xtampza ER (oxycodone) and Hysingla ER (hydrocodone), and now we have another to add to the list! The FDA recently approved Arymo ER (morphine), an extended-release tablet for the treatment of pain, and it is now available in pharmacies. See More
Coupon Notice: This drug is a controlled substance. Note that some pharmacies may not honor coupons for controlled substances.
Arymo ER Latest News
Get the latest updates on this drug from the GoodRx medical team
Roni Shye -
Copyright ©2018 GoodRx, Inc.
GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.